✨ With precision and technological innovation, Horizon Intelligence maps early observed phenotypes to gene variants, unlocking meaningful insights into the genetic underpinnings of rare diseases and cancer.
☄️ By analyzing these connections, Horizon Intelligence provides valuable genomic insights that is relevant to the phenotypes. Help identify the root causes of complex health conditions, offering a clearer path to understanding genetic origin of a condition.
☄️ By linking early symptoms to specific gene variants, it empowers healthcare professionals and individuals alike to make informed decisions, paving the way for personalized and effective solutions for a healthier future.
☄️By integrating a large language model with genome sequencing data, Horizon Intelligence analyzes billions of data points to deliver unparalleled precision, paving the way for a healthier, more informed future tailored just for you.
☄️ Horizon Intelligence is integrated with GenomeArc Horizon platform!
#genome #symptoms #rarediseases #cancer
Let’s plan for a demo request:
or Email: customercare@genomearc.com
#ai #genomics #HorizonAI #clinicalAI #clinicalgenomics #rarediseases #cancer #liquidbiopsy
About GenomeArc:
GenomeArc Inc. is a biotech company on clinical genetics and drug discovery headquartered in Mississauga, Ontario. The company began its journey in 2021, GenomeArc develops artificial intelligence integrated solutions for genetic diagnosis and genomic drug development solutions for rare genetic disorders and pan cancer. As a research-oriented biotech company, GenomeArc brings new insights into rare diseases, cancer diagnosis, and therapeutics through genome analysis. The GenomeArc team is constantly innovating technologies to solve phenotypic complexities in genetic variations for rapid intervention. As a global company, our aim is to make efficient and accurate genome medicine technologies accessible for all healthcare systems.
source
